|
|
| Model Number |
SYM3020 |
| Medical Device Problem Codes |
Mechanics Altered (2984); Adverse Event Without Identified Device or Use Problem (2993); Insufficient Device Problem Information (3190)
|
| Health Effect - Clinical Codes |
Adhesion(s) (1695); Emotional Changes (1831); Granuloma (1876); Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Unspecified Infection (1930); Inflammation (1932); Pain (1994); Scar Tissue (2060); Hernia (2240); Obstruction/Occlusion (2422); Ascites (2596); Unspecified Vascular Problem (4441); Nodule (4551); Unspecified Tissue Injury (4559); Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available (4581)
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
If information is provided in the future, a supplemental report will be issued.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced recurrence, small bowel obstruction, adhesions, pain, inflammation, defective device, mental pain, suffering, scarring, permanent impairment, and loss of enjoyment of life.Post-operative patient treatment included bowel resection, revision surgery, mesh removal, and partial mesh removal, lysis of adhesions, hospitalization, repair of the uterine wall.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information: a2, a3a, a4, b7, d4, d6b, g4 (pma/510k), h4.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional info: a1, b5, b6, b7, d4 (unique identifier (udi) #), g1, h6 (patient codes, device codes, ime e2402: hemoperitoneum), <(>&<)> additional codes medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
The patient¿s attorney alleged a deficiency against the device.The product was used for therapeutic treatment of a ventral hernia.It was reported that after implant, the patient experienced recurrence, small bowel obstruction, adhesions, pain, inflammation, defective device, mental pain, suffering, scarring, permanent impairment, loss of enjoyment of life, suture granulomas, vascular congestion, mass, hematoma, hemoperitoneum, fluid collection, stranding, hypotension, <(>&<)> wound infection.Post-operative patient treatment included bowel resection, revision surgery, partial mesh removal, mesh removal, lysis of adhesions, hospitalization, repair of the uterine wall, ct scan, x-ray, diagnostic lap, exploratory lap, repair of uterine wall, blood transfusion, icu, evacuation of hematoma, tpn, npo, ng tube, wound care, iv antibiotics, <(>&<)> use of drains.
|
| |
|
Search Alerts/Recalls
|
|
|